The enzyme arsenic (13 oxidation state) methyltransferase (As3mt) catalyzes reactions converting inorganic arsenic to methylated metabolites, some of which are highly cytotoxic. In a previous study, female As3mt knockout (KO) mice treated with diet containing 100 or 150 ppm arsenic as arsenite showed systemic toxicity and significant effects on the urothelium. In the present study, we showed that the cytotoxic and proliferative effects of arsenite administration on the urothelium are dose dependent. Female wild-type C57BL/6 mice and As3mt KO mice were divided into five groups (n 5 7) with free access to drinking water containing 0, 1, 10, 25, or 50 ppm arsenic as arsenite for 4 weeks. At sacrifice, urinary bladders of both As3mt KO and wild-type mice showed hyperplasia by light microscopy; however, the hyperplasia was more severe in the As3mt KO mice. Intracytoplasmic granules were detected in the urothelium of As3mt KO and wild-type mice at arsenic doses ‡ 10 ppm but were more numerous, more extensive, and larger in the KO mice. A no effect level for urothelial effects was identified at 1 ppm arsenic in the wild-type and As3mt KO mice. In As3mt KO mice, livers showed mild acute inflammation and kidneys showed hydronephrosis. The present study shows a dose-response for the effects of orally administered arsenite on the bladder urothelium of wildtype and As3mt KO mice, with greater effects in the KO strain but with a no effect level of 1 ppm for both.
Inorganic arsenic is a known human carcinogen affecting urinary bladder, skin, and lung following exposure to high levels, primarily from drinking water containing arsenic at concentrations above 150 lg/l (Chiou et al., 1995; Lamm et al., 2006; NRC, 1999 NRC, , 2001 . Inorganic arsenic occurs mainly in two oxidation states +5 and +3. The state-3 also occurs. The inorganic pentavalent arsenic (InAs +5 , or InAs V ) occurs as arsenic pentoxide, arsenic acid (H 3 AsO 4 ) and its salts, arsenates(V). The inorganic trivalent arsenic (InAs +3 , or InAs III ) occurs as arsenic trioxide, arsenous acid (HAsO 2 or H 3 AsO 3 ), and its salts, arsenites (III) . In this paper, we will use the terms ''arsenate'' or ''InAs V '' to denote inorganic compounds of pentavalent arsenic. The term ''arsenite'' or ''InAs III '' is used to denote inorganic compounds of trivalent arsenic. As V symbolizes any compound of pentavalent arsenic, and As III symbolizes any compound of trivalent arsenic. In humans and in most experimental animals, ingested inorganic arsenic undergoes metabolic reactions of sequential reductions and oxidative methylations to form organic trivalent and pentavalent arsenicals (Cohen et al., 2002 Le et al., 2000; Thomas et al., 2001; Wang et al., 2004) . Only a small amount of inorganic arsenic is excreted in the urine Vahter, 1994; Valenzuela et al., 2005) .
Once arsenate enters the gastrointestinal tract or is absorbed via another route, it is rapidly reduced to arsenite, which is oxidatively methylated to monomethylarsonic acid (MMA V , the monomethyl compound of pentavalent arsenic) by arsenic methyltransefase. MMA V is then reduced to monomethylarsonous acid (MMA III , the monomethyl compound of trivalent arsenic), which is methylated to dimethylarsinic acid (DMA V , the dimethyl compound of pentavalent arsenic) (Thomas et al., 2007) . In some species, such as the rat, DMA V is then reduced to dimethylarsinous acid (DMA III , the dimethyl compound of trivalent arsenic), which is methylated to trimethylarsine oxide thus forming mono-, di-, and trimethylated arsenic metabolites. This methylation pathway has long been regarded as a detoxification process (Vahter, 1983) ; however, some of the intermediates formed during the methylation process (e.g., MMA III and DMA III ) are highly reactive and more cytotoxic in vitro than InAs III (Cohen et al., 2002; Petrick et al., 2000; Styblo et al., 2000) . Hence, the methylation pathway may be responsible for some of the toxic and carcinogenic effects commonly associated with exposure to inorganic arsenic (Le et al., 2000; Thomas et al., 2001) . In addition, the metabolism of arsenic also involves conversion of methylated oxy-arsenicals to the corresponding methylated thio-arsenicals , which may be more toxic than the corresponding pentavalent oxy-arsenicals . Cytotoxic effects on the urothelium with consequent regenerative proliferation and the ultimate development of tumors have been induced by arsenicals in rats (Cohen et al., , 2007a and mice (Cohen et al., 2007a; Waalkes et al., 2006) . We hypothesized that reactive methylated arsenicals produced during metabolism of inorganic arsenic bind to sulfhydryl groups of critical cellular proteins in the urinary bladder epithelium, leading to urothelial cytotoxicity and regenerative proliferation and, eventually, to tumors (Cohen et al., 2007a) . The cytosolic enzyme, arsenic (þ3 oxidation state) methyltransferase (As3mt), catalyzes reactions involved in the reduction and oxidative methylation of arsenicals (Hester et al., 2009; Thomas et al., 2007 Thomas et al., , 2010 . Therefore, it was of interest to investigate the effects of inorganic arsenic exposure in mice with a null genotype for As3mt. Initial studies with As3mt knockout (As3mt KO) mice revealed that inhibition of arsenic methylation resulted in altered clearance of arsenic and its tissue distribution . Previously, we examined the effect of dietary InAs III on the urinary bladder epithelium in As3mt KO mice and in wild-type mice in which the capacity of enzymatically catalyzed methylation of arsenic was intact (Yokohira et al., 2010) . The effects of inorganic arsenic on the urinary bladder epithelium in the As3mt null genotype were potentiated, suggesting that the methylated metabolites of inorganic arsenic were not required for cytotoxicity in this target tissue. During the first week of dietary InAs III exposure in this study, As3mt KO mice exhibited severe systemic toxicity that was lethal to some (Yokohira et al., 2010) . Doses were reduced, and the dietary route of exposure was changed to treatment through the drinking water. At sacrifice, after exposure for 2 weeks or less, the urinary bladders of both As3mt KO and wild-type mice showed urothelial hyperplasia by light microscopy. Inorganic arsenic, arsenite, and arsenate produce intramitochondrial granules in the urothelium of mice, which were found to contain arsenic predominantly as InAs III (Suzuki et al., 2008a (Suzuki et al., , 2008b . In As3mt KO mice, the arsenic-containing granules were present in all layers of the bladder epithelium and were larger and more abundant than in wild-type mice. Also, severe acute inflammatory changes in the liver were observed in As3mt KO mice, and spleen size, especially the lymphoid areas, was decreased compared with wild-type mice.
In view of these observations, we have modified our hypothesis. The revised hypothesis is that ''trivalent arsenicals,'' methylated and nonmethylated, bind to sulfhydryl groups of critical proteins in the urinary bladder epithelium, leading to cytotoxicity and regenerative proliferation and eventually to tumors. Differences in kinetics between strains and species determine the relative concentrations of the various trivalent forms excreted in the urine. The objective of this study was to examine the proliferative lesions of the bladder epithelium induced by exposure to trivalent arsenicals (As III ) for a longer experimental period (4 weeks) and to determine if the cytotoxic and proliferative effects of As III in the urothelium are dose dependent.
MATERIALS AND METHODS
Chemicals. Sodium arsenite (NaAsO 2 , anhydrous 99%) was purchased from Sigma (St Louis, MO), stored desiccated at room temperature, and used as received without additional analysis. Arsenite was used for these experiments as we have previously shown similar responses of the bladder following arsenate or arsenite administration (Suzuki et al., 2008b) .
As3mt KO mice. Two male and four female mice homozygous for the disrupted As3mt gene were obtained from Dr David Thomas (U.S. Environmental Protection Agency, Research Triangle Park, NC). The homozygous As3mt KO mice were developed by deletion of exons 3 through 5 of the As3mt gene after homologous recombination. The altered gene was introduced and maintained in strain 129S6 mice and then introduced into strain C57BL/6 mice by marker-assisted accelerated backcrossing performed by Charles River Laboratories (Wilmington, MA) to produce homozygous As3mt À/À mice. The As3mt KO mice are fertile, so brother/sister matings were used to maintain the homozygous As3mt KO genotype. Upon arrival at the University of Nebraska Medical Center, animals were placed in quarantine and housed on aspen wood shavings in polycarbonate cages with micro-isolator tops in a high efficiency particulate air-filtered, flexible film isolator in a quarantine facility accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC). The isolator was targeted at a temperature of 22°C, relative humidity of 50%, and a 12-h light/dark schedule (0600/1800 h Central Standard Time [CST] ). Mice were provided with diet (irradiated Teklad 2018S with Fenbendazole, Harlan Teklad, Madison, WI) and water (hyperchlorinated [< 10 ppm chlorine] reverse osmosis [RO] ) ad libitum. After release from quarantine, the mice were moved to the transgenic area of the AAALAC-accredited facility with targeted environmental conditions as described above. The mice were housed on dry corncob bedding and provided with diet (autoclaved, pelleted Teklad 7012 diet designed for rodent breeding, Harlan Teklad) and water (hyperchlorinated, RO) ad libitum. Nestlets and mouse houses were added to the cages for environmental enrichment. During mating, one to two females were housed with one male. Once pregnancy was noted, a female was separated from the male and housed individually. Pups were weaned at 21 days of age or later and group housed (maximum five animals per cage) based on dam and sex.
Animal experiment. Thirty-five female wild-type C57BL/6 mice (Charles River Breeding Laboratories, Raleigh, NC), 8 weeks old at the time of arrival, were placed in an AAALAC-accredited facility and quarantined for 8 days prior to treatment. Thirty-five female As3mt KO mice from the F2 generation, approximately 9-11 weeks old, were transferred from the breeding colony to the same room with wild-type mice. The level of care provided to the animals met or exceeded the basic requirements outlined in the Guide for the Care and Use of Laboratory Animals (NIH Publication #86-23, revised 1986) . All animals were housed in polycarbonate cages (three to four per cage) with micro-isolator tops and dry corncob bedding. Nestlets were added to the cages for environmental enrichment. The animal room was targeted at 22°C and 50% relative humidity and placed on a 12-h light/dark schedule (0600/1800 h CST).
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All mice were provided with pelleted Purina 5002 (Dyets Inc., Bethlehem, PA), a standard rodent chow, and water (hyperchlorinated, RO). Food and water were provided ad libitum throughout the study.
At approximately 9-12 weeks of age, animals were randomized into five treatment groups per genotype (seven per group) using a weight stratification method (Martin et al., 1986) . Groups 1-5 were composed of As3mt KO mice and groups 6-10 were wild-type mice. Drinking water was changed from hyperchlorinated RO water to the tap water in the animal rooms in order to treat the mice with NaAsO 2 dissolved in the drinking water. Groups 1 and 6 were provided tap water with no test substance added, groups 2 and 7 were treated with 1.73 ppm NaAsO 2 (1 ppm InAs III ), groups 3 and 8 were treated with 17.3 ppm NaAsO 2 (10 ppm InAs III ), groups 4 and 9 were treated with 43.3 ppm NaAsO 2 (25 ppm InAs III ), and groups 5 and 10 were treated with 86.5 ppm NaAsO 2 (50 ppm InAs III ). Based on stability studies performed for the National Toxicology Program (Reed et al., 2001) , the NaAsO 2 -containing water was prepared fresh every Monday and Thursday. The same schedule was used to change the drinking water on the control cages.
Body weights of all wild-type animals were measured the day after arrival. Body weights for all animals were measured, prior to randomization, on study day 0 and on the day of sacrifice. Animals treated for 4 weeks were also weighed on study days 7, 14, 21, and 28. One As3mt KO mouse treated with 50 ppm In As III was found dead on study day 5. The six other mice in the same group became moribund before the scheduled sacrifice after treatment for 4 weeks, and therefore, all As3mt KO mice and wild-type mice from the 50 ppm InAs III groups, as well as three mice from the two control groups (As3mt KO and wild type), were sacrificed on study day 6. The remaining animals were terminated after 4 weeks of treatment.
At sacrifice, the urinary bladders were inflated in situ with Bouin's fixative, and after removal, the bladders were placed in Bouin's fixative (Cohen et al., 2007b) . A small section of intestine was removed and placed in Bouin's fixative with the bladder. Following fixation, the Bouin's-fixed bladders and intestinal tissue were rinsed in 70% ethanol, the bladders were weighed, and all tissues were observed macroscopically. The bladders were divided in half longitudinally. One half of each bladder was cut longitudinally into strips and was embedded in paraffin with a slice of intestinal tissue, stained with hematoxylin and eosin (H&E), and examined histopathologically (Cohen, 1983; Cohen et al., 1990 Cohen et al., , 2007b . A diagnosis of mild simple hyperplasia was made when there were four to five cell layers in the bladder epithelium and moderate hyperplasia when six to eight cell layers were present. The other half of each bladder was examined by scanning electron microscopy (SEM) and classified in one of five categories as previously described (Cohen et al., 1990) . Briefly, class 1 bladders have polygonal superficial urothelial cells; class 2 bladders have occasional small foci of superficial urothelial necrosis; class 3 bladders have numerous small foci of superficial urothelial necrosis; class 4 bladders have extensive superficial urothelial necrosis, especially in the dome of the bladder; and class 5 bladders have necrosis and piling up (hyperplasia) of rounded urothelial cells. Normal rodent urinary bladders are usually class 1 or 2, or occasionally class 3. The liver, spleen, and kidneys were also removed and weighed, and the lungs were removed and inflated with formalin via the trachea. These organs were placed in formalin and embedded in paraffin, stained with H&E, and examined histopathologically.
Unstained slides of the bladder and intestinal tissue were used for immunohistochemical detection of bromodeoxyuridine (BrdU) (Cohen et al., 2007b) . The intestinal tissue served as a positive control. Anti-BrdU (Millipore Corporation, Temecula, CA) was used at a dilution of 1:200. The number of BrdU-labeled cells in at least 3000 urothelial cells (all layers) was counted to determine a labeling index.
Statistics. Food and water consumption data were available for only one cage in the As3mt KO and wild-type control groups; therefore, statistical analysis was not performed. The group means for body weights and tissue weights were evaluated using ANOVA followed by the Duncan's multiple range test for groupwise comparisons. Histopathology was compared using the two-tailed, Fisher's exact test. SEM data were analyzed using one-way nonparametric procedures followed by a chi-square test. p Values less than 0.05 were considered significant. These statistical analyses were performed using SAS for Windows (Version 9.1).
RESULTS

Morbidity and Mortality
One As3mt KO mouse treated with 50 ppm In As III was found dead on study day 5. The remaining six mice in this group were sacrificed on study day 6 due to signs of severe acute toxicity. In addition, all wild-type mice treated with 50 ppm In As III and selected control mice (three As3mt KO and three wild type) were also sacrificed on day 6. Due to autolysis, a necropsy was not performed on the As3mt KO animal, which died on study day 5. Necropsies were performed on all animals sacrificed on study day 6. Treatment of all remaining mice continued through the full 4-week experimental period. One As3mt KO mouse treated with 25 ppm InAs III showed mild symptoms of arsenic poisoning, including body tremors, decreased activity, and an unsteady gait by the end of the experimental period and was sacrificed 4 days prior to the scheduled sacrifice date for the rest of the group.
Body Weights, Water and Food Consumption, and Tissue Weights The day 6 body weights of As3mt KO mice treated with 50 ppm InAs III were significantly decreased compared with those of the control As3mt KO mice and of the wild-type mice administered 50 ppm InAs III (Supplementary table 1) . After treatment for 4 weeks, weight gains in the As3mt KO control mice and in the As3mt KO mice exposed to 1 and 10 ppm InAs III were larger than weight gains of mice from the comparable wild-type groups. However, this probably was because the As3mt KO mice were 2 weeks older than the wildtype mice. In the As3mt KO mouse group treated with 25 ppm InAs III , the body weight gain was less than in the wild-type group treated with 25 ppm InAs III , resulting in similar mean body weights in these two groups on day 28.
Due to the early sacrifice date, water and food consumption were not measured in the As3mt KO or wild-type mice treated with 50 ppm InAs III . For all other treatment groups, there were no intergroup differences in water and food consumption (Supplementary table 2) .
For mice sacrificed on study day 6, the relative kidney weights of the As3mt KO mice treated with 50 ppm InAs group. The absolute (not normalized for body weight) kidney weights in the As3mt KO mice treated with 10 and 25 ppm InAs III were significantly increased compared with those of the As3mt KO control group. The absolute kidney weights in all As3mt KO groups were significantly increased compared with the corresponding wild-type group; however, this probably was due to the 2-week difference in age between the two genotypes.
Histopathology
Simple hyperplasia was observed in the bladder epithelium of all six As3mt KO mice and five of seven wild-type mice treated with 50 ppm InAs III and in none of the control As3mt KO mice or control wild-type mice sacrificed on study day 6 (Fig. 1) ( Table 1 ). The hyperplasia was more pronounced in the As3mt KO mice (moderate) compared with the wild-type mice (mild). Necrosis of the superficial layer of the epithelium with exfoliation and focal erosion was also observed in the As3mt KO mice treated with 50 ppm InAs III . A few intracytoplasmic eosinophilic granules (Suzuki et al., 2008a) were observed in the superficial epithelial layer of the bladder of one control As3mt KO mouse and in four of six As3mt KO mice and one of four wild-type mice treated with 50 ppm InAs III . After treatment for 4 weeks, simple hyperplasia of the bladder epithelium was detected in all As3mt KO mice treated with 10 and 25 ppm InAs III and in six of seven wild-type mice in each of these two groups (Fig. 2) , and in all mice treated with 25 ppm InAs III . There were no granules present in the urothelium of the wild-type control mice. In the treated wild-type mice, the granules were located only in the superficial layer of the urothelium, whereas in the treated As3mt KO mice, granules were present in all layers of the urothelium in the 25 ppm InAs III As3mt KO mouse group, and the granules were located not only in the cytoplasm of the urothelial cells but also in the nucleus at 10 and 25 ppm InAs III . The granules were also larger and more plentiful in the As3mt KO mice compared with the wild-type mice.
The kidneys showed no remarkable histopathological changes in any mice sacrificed during the first week. After treatment for 4 weeks, hydronephrosis was observed in the kidneys of three of seven As3mt KO mice treated with 25 ppm InAs III (Table 3) . Intracytoplasmic eosinophilic granules were also observed in the urothelial epithelium of the kidney pelvis in the As3mt KO mice treated with 1, 10, and 25 ppm InAs III (Fig. 3) , but not in any As3mt KO control mice. Granules were observed in the urothelial epithelium of the kidney pelvis of only one wild-type mouse treated with 25 ppm InAs III . Urothelial vacuolization indicative of necrosis was observed in one wild-type mouse treated with 10 ppm InAs III and in one As3mt KO mouse and two wild-type mice treated with 25 ppm InAs III . No remarkable histopathological changes were noted in the liver of any mice sacrificed during the first week or in the lungs of any mice sacrificed at either time point. Mild hepatitis (Yokohira et al., 2010) was observed in livers from three of the seven As3mt KO mice treated with 25 ppm InAs III (Table 3 ) for 4 weeks.
Scanning Electron Microscopy
The three bladders examined in the group of As3mt KO mice treated with 50 ppm InAs III and sacrificed on day 6 were classified as class 2, which is considered within the normal range for rodents (Cohen et al., 1990) . We were unable to examine the remaining three bladders in the group by SEM due to the presence of a glycocalyx on the surface of one bladder and inadequate inflation of two bladders. There was extensive necrosis and exfoliation of the urothelium in bladders from four of six of the wild-type mice treated with 50 ppm InAs III . After treatment for 4 weeks, the incidence of class 5 bladders was significantly increased in the As3mt KO mice treated with 25 ppm As III , but bladders in all other As3mt KO mice and wild-type mice were normal by SEM (Fig. 4 , Table 2 ). The bladders in the 25 ppm InAs III As3mt KO group showed cytotoxicity, necrosis, and piling up of small round urothelial cells indicative of proliferation and hyperplasia (Fig. 4A) .
BrdU Labeling Index
On day 6, the BrdU labeling index of the bladder urothelium was similar in the As3mt KO and the wild-type mice treated with 50 ppm InAs III when compared with their respective controls and to each other (Table 1) . After treatment for 4 weeks, there was no increase in the BrdU labeling index in any of the As3mt KO mouse treatment groups. There was an increase in the mean labeling index in all treated wild-type groups compared with control; however, the increase was not statistically significant for any treatment group. (group 9) . There were granules in the superficial epithelial layers of the bladders (arrows) in (A, B, C, D, G, and H). Moderate simple hyperplasia was present in the bladders in (D and H), and mild simple hyperplasia was present in the bladders in (C and G). In the 10 and 25 ppm InAs III -treated As3mt KO mice, the granules occurred in all layers of the epithelium (C and D), and granules were present in the nucleus (arrowheads) in the As3mt KO mice treated with 25 ppm InAs III (group 4, D). Wild-type control mice showed normal epithelium (E). Magnification 3400.
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DISCUSSION
We originally hypothesized that without formation of reactive trivalent methylated arsenicals (MMA III and DMA III ) in the As3mt KO mouse, there would be no adverse effect on the urothelium following administration of inorganic arsenic . However, clear evidence of cytotoxicity and regenerative proliferation was observed in the urothelium of As3mt KO mice treated with 150 and with 100 ppm InAs III (Yokohira et al., 2010) . We were only able to evaluate one mouse bladder from the As3mt KO group treated with 150 ppm As III because of early deaths of the other mice from this group. Bladders from As3mt KO mice treated with 100 ppm InAs III , examined by SEM, showed evidence of severe epithelial cytotoxicity, frequently in association with increased proliferation and hyperplasia (piling up of small round cells).
In the present experiment, histopathologically simple hyperplasia of the bladder epithelium was detected in all As3mt KO mice treated with 10, 25, or 50 ppm InAs III . In the As3mt KO mice treated with 50 ppm InAs III , pronounced necrosis of the superficial layer with exfoliation of the superficial cells was also evident. In the wild-type mice treated with 10, 25, or 50 ppm InAs III , all but one mouse in each of the 10 and 25 ppm groups also had simple hyperplasia of the bladder epithelium. There was no hyperplasia detected in the As3mt KO mice treated with 1 ppm InAs III , and only one wild-type mouse treated with 1 ppm InAs III had hyperplasia, which is well within the control range for mice at this age. This lack of effect at 1 ppm InAs III is similar to the no effect level of 2 ppm DMA V (1.1 ppm As v ) administered in the diet (Arnold et al., 1999) and 1 ppm arsenite (Suzuki et al., 2008b) observed in rat bladder. The incidence of simple hyperplasia was increased in a similar dose-dependent manner in both As3mt KO and wild-type mice treated with 10, 25, and 50 ppm InAs III . We have previously reported the presence of numerous intracytoplasmic eosinophilic granules in the superficial cells of the urothelium of In As III -treated mice (Suzuki et al., 2008a) . We have demonstrated that these granules are intramitochondrial and that they contain large amounts of arsenic, predominantly as arsenite Suzuki et al., 2008a,b) . These granules were found to be more pronounced in As3mt KO mice than in the wild-type mice (Yokohira et al., 2010) . In the As3mt KO mice, the granules were bigger and more plentiful, and they appeared to involve all layers of the urothelium. By light microscopy, the granules in the As3mt KO mice appeared to accumulate also within the nuclei of the urothelial cells in addition to the cytoplasm. The abundance and location of these granules in As3mt KO mice is likely due to the accumulation of very high concentrations of inorganic arsenic in the urothelial cells of these animals .
Clearly, in As3mt KO mice and in wild-type mice, cytotoxicity with regenerative proliferation of the urothelium occurred following acute oral arsenite administration, although there was no methylation or consequent formation of highly reactive trivalent methylated arsenicals in the As3mt KO mice. Therefore, the uroepithelial injury was likely the consequence of excretion of high levels of inorganic arsenic in the urine and retention in the urothelium Hughes et al., 2010) . Although somewhat less toxic than trivalent methylated arsenicals, arsenite (trivalent ''inorganic arsenic'') is cytotoxic in vitro at low micromolar concentrations (0.75-8.3lM), whereas the methylated trivalent arsenicals are cytotoxic at concentrations of 0.1-1.0lM . In wild-type mice, like humans, there is little inorganic arsenic excreted in the urine following exposure to inorganic or organic arsenic, even at high exposure levels. Most of the arsenic excreted in wild-type mice is methylated Kenyon et al., 2005 Kenyon et al., , 2008 . In contrast, in the KO mice, the arsenic is excreted primarily as arsenite (Drobna et al., 2005 . It is highly likely that concentrations of the reactive trivalent arsenicals of such order of magnitude that produce cytotoxicity are achieved in the urine of mice administered 10 ppm InAs III and higher but not in mice treated with 1 ppm InAs III (El-masri and Kenyon, 2008; Kenyon et al., 2005 Kenyon et al., , 2008 Suzuki et al., 2010) . We conclude that a critical level of trivalent arsenicals, methylated or inorganic, must be achieved in the urine for induction of urothelial cytotoxicity with consequent regenerative proliferation. If it is inorganic trivalent arsenic, a higher concentration would be expected to be required than for the methylated trivalent arsenicals . If sustained, this increase in urothelial proliferation ultimately can result in a low incidence of bladder tumors (Cohen, 1998; Tokar et al., 2011; Waalkes et al., 2006) . In As3mt KO mice, nearly all the trivalent arsenic present in the urine following treatment with arsenate was inorganic, whereas in wild-type mice that received the same treatment, most of the trivalent arsenic in the urine was methylated El-Masri and Kenyon, 2008; Hughes et al., 2010; Kenyon et al., 2005 Kenyon et al., , 2008 . The association between dose and the cytotoxic effect on the urothelium in both the As3mt KO mice and the wild-type mice corresponds well with the concentrations previously observed to cause cytotoxicity in vitro in rat (MYP3) or human urothelial cells (UROtsa or 1T1) (Cohen et al., 2002) , which have no As3mt activity (Drobna et al., 2005; Sen et al., 2007; Styblo et al., 2002) . The difference between wild-type and As3mt KO mice is that the cytotoxic and proliferative effects are caused by the methylated trivalent arsenicals expected in wild-type mice (Kenyon et al., 2005 and trivalent inorganic arsenic in the KO mouse (Drobna et al., 2005 ). The effect on the bladder epithelium is the same, the difference being in metabolism and kinetics.
In a previous experiment, severe hepatic inflammation with inflammatory cell infiltration, increased apoptosis, and cytoplasmic vacuolation was observed only in livers of the As3mt KO mice and not in the livers of wild-type mice treated with arsenite (Yokohira et al., 2010) . In the present experiment, As3mt KO mice treated with arsenite showed less inflammatory or other changes in the liver, but the doses in the present experiment were less than in the previous study. No liver toxicity was observed at doses of 10 ppm or lower (a higher no effect level [NOEL] than for the bladder epithelial changes). Based on the results of both experiments, severe inflammatory changes in the liver appear to be induced by acute toxicity in the As3mt KO mice, secondary to treatment with high doses of arsenite. These changes were not observed in wild-type mice in the present experiment and have not been observed in wildtype mice administered inorganic arsenic for longer periods of time (Waalkes et al., 2006) . These results indicate that in the broader sense, methylation does represent a detoxification mechanism for arsenic. Treatment of As3mt KO mice with arsenite also induced dramatic changes in the kidney, which were not observed in the previous study when mice were treated for only 9 days (Yokohira et al., 2010) . It is highly likely that the kidney effects occurred in the present experiment because of the longer treatment period (28 days). An unexplained incidence of hydronephrosis was observed in the As3mt KO mice and tended to increase with dose. The NOEL for the kidney effects also was 10 ppm. The presence of hydronephrosis in one mouse in each of the 0, 1, and 10 ppm groups of KO mice suggests that this is an effect that can occur spontaneously, whereas it is not seen in the wild-type mouse, either control or arsenic treated, even when treated for longer periods of time (Dunn, 1967; Tokar et al., 2011) .
The present experiment demonstrates a clear dose-response relationship between arsenite and toxicity in the liver, kidney, and bladder of As3mt KO mice and for cytotoxicity and proliferative activity in the bladder epithelium of both As3mt KO and wild-type mice, the most sensitive end point being the changes in the liver. There was no significant difference between the dose-response relationship for the bladder epithelial effects in As3mt KO and in wild-type mice. These results support our hypothesis that urothelial cytotoxicity is induced by reactive trivalent arsenicals, inorganic or methylated, in the urine and that a critical minimum concentration needs to be achieved before cytotoxicity is induced. Cytotoxicity is the initial effect of As III on the urothelium, resulting in subsequent urothelial proliferation and ultimately tumors.
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